CW November 2004

category image Volume 13
Issue Number 11
November 2004
ISSN 10593802

Quality-of-Life Study for Breast Cancer Drugs

Anastrozole, an aromatase inhibitor that is used as adjuvant therapy for breast cancer patients, is found to work better than tamoxifen in warding off cancer recurrence and produces different side effects that might warrant consideration when choosing the best therapy.
Go to Previous Page
Go to Next Page

Source & Additional Reading

D. Cella et al., Journal of Clinical Oncology, November 1, 2004.

Purchase Downloadable Full-text PDF of Article: $10.00

Subscription is more cost effective than purchasing PDFs on-the-fly.  Click here for details.

Download Complete Issue CW November 2004

Purchase Downloadable Full-text PDF of Complete Issue: $20.00


Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us

Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA
phone: 518-456-0784; fax: 518-452-4955; email: info@adeninepress.com
copyright © Adeninepress, All rights reserved.




Re-initialize IP-based Login